Company / Operating Cash Flow per Share
Acadia Pharmaceuticals Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.66
FY2025
5-year range
-$0.79 / $0.96
FY2021-FY2025
Trend
-31.2%
vs FY2024
Sector context
#62 of 212
Health Care
What the data says
At $0.66, Acadia Pharmaceuticals's operating cash flow per share ranks #62 of 212 in the Health Care sector. Improved from $0.10 to $0.66 over the past 2 years.
Based on SEC 10-K filings.
0.66 in FY2025.
Improved from $0.10 to $0.66 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#62 of 212 in Health CareTop 29% of 212This company $0.66 Sector average $5.28
▼
-87.5% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 31.2% year-over-year.
- Ranks #62 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2024.
- Lowest operating cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.66 | -31.2% |
| FY2024 | $0.96 | +829.5% |
| FY2023 | $0.10 | +114.6% |
| FY2022 | -$0.71 | +10.0% |
| FY2021 | -$0.79 | +10.2% |
| FY2020 | -$0.88 | +16.5% |
| FY2019 | -$1.05 | +22.0% |
| FY2018 | -$1.35 | +25.0% |
| FY2017 | -$1.79 | +12.2% |
| FY2016 | -$2.04 | -67.9% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026